|
A bioequivalence study to compare the currently marketed formulation of augmentin with the ES 600 Strawberry Cream Suspension (4A) |
amoxicillin/clavulanic acid |
25000/643 |
|
Infections, Bacterial |
Phase 1 |
|
|
|
|
An analysis-ready dataset, an annotated case report form, and reporting and analysis plan are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
June 2014 |